Brief: Calmark Sweden: Products For Biomarkers, LDH And Glucose Will Not Obtain CE Conformity Markings Until Q1 2020

Calmark Sweden AB

18/10/2019 14:39

Oct 18 (Reuters) - Calmark Sweden AB  CALMAb.TE :
    * CALMARK EXTENDS THE TIME PLAN FOR CE-MARK OF THE
BIOMARKERS LDH
AND GLUCOSE - MARKET LAUNCH AS ACCORDING TO PLAN
    * ANNOUNCES TODAY THAT COMPANY'S PRODUCTS FOR BIOMARKERS,
LDH AND
GLUCOSE, WILL NOT OBTAIN THEIR CE CONFORMITY MARKINGS UNTIL Q1
OF 2020, MARKET LAUNCH OF PRODUCTS WILL NOT BE AFFECTED
    * COMPANY HAS FOCUSED ITS EFFORTS ON FIRST BIOMARKER,
BILIRUBIN,
WHOSE CE-MARK IS ON SCHEDULE, AND ON RAMPING UP PRODUCTION LINES
TO FACILITATE MARKET LAUNCH

Source text for Eikon:  ID:nWkr9kZsqF 
Further company coverage:  CALMAb.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587785110;))